ArticleArchives of osteoporosis2026
Patients' lived experiences of fractures during immune checkpoint inhibitor therapy: a qualitative study.
Article in Archives of osteoporosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fractures during or after immune checkpoint inhibitor therapy were experienced as "a small price to pay" relative to cancer survival. Despite their functional and psychological impact, patients emphasized the importance of rehabilitation and more transparent communication regarding fracture risks.
backgroundWhile bone fractures following immune checkpoint inhibitor (ICI) therapy have been increasingly reported, patients' lived experiences and the associated functional and psychological consequences are not well understood. This study aimed to evaluate patients' descriptions of their fracture experiences during and after their ICI therapy.
methodsIn this qualitative descriptive study, 15 patients who experienced fractures during or after ICI therapy were interviewed. Participants were recruited between March 2024 and July 2025. Semi‑structured interviews were audio‑recorded, transcribed verbatim, and analyzed using Braun and Clarke's thematic analysis approach. Coding was conducted independently by a single researcher and subsequently reviewed by the full research team.
resultsThe analysis showed that fracture experiences were interpreted within the context of a core theme: "a small price to pay." Participants viewed fractures as less important when compared with the risk of mortality from cancer. They demonstrated different pathways of adaptation and recovery, highlighting the importance of physical rehabilitation and the need for empathy from healthcare providers. Additionally, although patients were unaware of the association between immunotherapy and bone fractures, they noted that this information would not have changed their initial desire to receive treatment, although it would have been helpful in providing them with better insight and a greater sense of control.
conclusionBone fractures in ICI recipients have a significant impact on patients' overall functioning, although they do not diminish patients' desire to continue treatment. Providing patients with information about these risks helps them prepare for injury prevention and manage the unintended consequences.
Indexed as
Identifiers
42909707What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.